Bioprocessing - Upstream & Downstream

Academia suggests we need to upgrade lyophilization, but scientists are being slow to respond

The use of multimodal chromatography is increasing in biopharma purification processes. Here’s why.

Discover how Asahi Kasei Bioprocess is engineering a streamlined approach to chromatography media preparation.

Sitting Down With Dick Sundh, General Manager, Kite Pharma

We delve into the story behind Lonza’s collaboration with Asahi Kasei Bioprocess America.

The potential of the cell and gene therapies sector depends – partially – on the expertise of the transport and logistics partners that complement it.

How can companies beat the bottlenecks in viral vector manufacturing?

What lies ahead for biopharma manufacturers when it comes to downstream analytical tech?

While contamination issues continue to limit the potential of gene therapy, scientists can no longer afford to ignore the best detection methods.

Who are the most influential and inspirational people in drug development and manufacturing? Nominations for the Power List 2024 are now open!